AVAH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Aveanna Healthcare Holdings Inc (AVAH) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite revenue growth, the company's declining net income and EPS, coupled with neutral trading trends and lack of positive catalysts, suggest limited upside potential. The technical indicators and options data also do not support a compelling entry point.
The MACD histogram is negative and contracting (-0.0535), RSI is at 35.165 (neutral zone), and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 7.741), but no strong bullish signals are present.
Revenue increased by 22.18% YoY in Q3 2025, and gross margin improved by 4.28% YoY.
Net income dropped by -132.83% YoY, and EPS declined by -127.27% YoY. No recent news, no significant hedge fund or insider trading activity, and no congress trading data.
In Q3 2025, revenue grew to $621.94M (+22.18% YoY), but net income fell to $14.06M (-132.83% YoY), and EPS dropped to $0.06 (-127.27% YoY). Gross margin improved to 32.19% (+4.28% YoY).
No data on analyst ratings or price target changes is available.
